facebook
HomeNews

News

image

UHC Expanding Accumulator Programs for Provider Administered Drugs

posted: October 16, 2020 to Federal

Accumulator adjustment programs are a utilization management tool that prevent the value of co-pay assistance from applying to a patient’s deductible, leaving patients vulnerable to high out-of-pocket expenses when the value of their co-pay assistance runs out.

READ MORE

image

New Phase 3 Provider Relief Funds Announced

posted: October 2, 2020 to Federal

The COVID-19 pandemic has substantially disrupted many private medical practices across the country. New operational expenses, reduced service and revenues, and other variables have threatened the viability of many of these practices. Rheumatology has not remained unscathed.

READ MORE

image

Recapping the 2020 State Society Advocacy Conference

posted: September 18, 2020 to CSRO News

CSRO hosted its annual State Society Advocacy Conference. While this was the 8th iteration of the SSAC, it also marked the first time the conference occurred in a virtual format. Despite the venue changed forced by the pandemic, CSRO was pleased to present an excellent program with strong attendance.

READ MORE

image

Report Details Prevalence of Accumulator Adjustment Programs

posted: August 21, 2020 to CSRO News

Accumulator adjustment programs are a newly emergent utilization management tool used by PBMs, that have grown increasingly prevalent over the past few years. The programs prevent the value of co-pay assistance from applying to a patient’s deductible, leaving patients vulnerable to high out-of-pocket expenses when the value of their co-pay assistance runs out.

READ MORE

CSRO Continues Advocacy Opposing BCBST White-bagging Policy

posted: July 24, 2020 to CSRO News

CSRO Opposes BCBST White-bagging Policy

READ MORE

image

HHS Issues Slew of Clarifications for Provider Relief Fund Recipients

posted: June 26, 2020 to Federal

After announcing plans to distribute an addition $15 billion to participants in state Medicaid and CHIP programs, the Department of Health and Human Services issued a number of clarifications for providers who received funds from the general distribution fund.

READ MORE

image

CSRO Renews Opposition to BCBST Whitebagging Policy

posted: June 12, 2020 to CSRO News

Late last year, Blue Cross Blue Shield of Tennessee (BCBST) announced a sweeping policy that would mandate the use of a white-bagging acquisition system for a substantial number of covered lives in Tennessee. The policy would have, in effect, disallowed the use of buy and bill.

READ MORE

image

Updates to Louisiana Step-therapy Reform Statute Advance through Legislature

posted: May 29, 2020 to State

For Louisianans with chronic health conditions, it is important to get timely access to the medications and treatments they need. We must ensure that doctors and their patients, not a one-size-fits-all insurance policy, make the right decision for the right treatment at the right time.

READ MORE

image

CSRO Comments on CMS Telehealth and Home Administration

posted: April 30, 2020 to Federal

In response to rapidly evolving circumstances surrounding the COVID-19 pandemic, CMS has made numerous interim revisions to its policies. These changes are designed to streamline patient access to care during the pandemic and large scale social distancing.

READ MORE

image

South Dakota Becomes Latest State to Enact Step Therapy Reform

posted: April 21, 2020 to State

On Tuesday, March 24th South Dakota Governor, Kristi Noem, signed SB 155 into law as S.J. 588. The law provides sorely needed reforms to the step-therapy process for patients and providers in South Dakota.

READ MORE

Add to the COVID-19 Global Rheumatology Alliance Registry

posted: April 8, 2020 to CSRO News, Federal

CSRO is imploring its membership to utilize the COVID-19 Global Rheumatology Alliance Healthcare Provider Entered Registry during the unprecedented era of global pandemic.

READ MORE

CSRO Leadership Gives Testimony at FDA/FTC Biosimilar Workshop

posted: March 25, 2020 to CSRO News

On March 9, 2020, the Federal Trade Commission and the Food and Drug Administration co-sponsored a public workshop focusing on promoting competition in biologics markets. The workshop was held at the FDA’s White Oak Campus in Silver Spring, Maryland and was also viewable via webcast.

READ MORE

image

CSRO 2020 Fellows Conference Round-Up

posted: March 17, 2020 to CSRO News

On March 7th, 2020, the CSRO held its annual Fellows Conference in San Francisco. Attending fellows were introduced to a network of experienced physicians that they can tap into as they prepare for their futures.

READ MORE

CSRO Policy Update, March 2020, Issue 10

posted: March 10, 2020 to Policy Update

With the turning of the decade I have recently been reflecting on CSRO’s growth and achievements over the course of the past ten years.

READ MORE

Statement from CSRO President On New BCBST Policy

posted: February 12, 2020 to CSRO News

Following a press release issued by BlueCross BlueShield of Tennessee attacking the Coalition of State Rheumatology Organizations for exposing a policy that will prove to harmful to patients, Dr. Madeline Feldman, CSRO’s President, issued this statement.

READ MORE

image

CSRO Releases New Legislative Map Tool Resource

posted: February 10, 2020 to CSRO News

CSRO has developed a new legislative map tool which serves as a clearinghouse of both active bills and enacted legislation.

READ MORE

CSRO Opposes New Policy by BCBS Tennessee

posted: January 29, 2020 to CSRO News, Federal

CSRO physicians are voicing concern for patients who will fall victim of a dangerous new prescription policy. New requirements from BlueCross BlueShield (BCBS) of Tennessee, which may be a bellwether for other insurers, are reversing the trend providers have achieved in keeping prices down for physician administered medications.

READ MORE

image

Florida Rep. Jackie Toledo Going After the PBM Problem

posted: December 19, 2019 to State

This week, Jackie Toledo, a member of the Florida House of Representatives, filed legislation that would lower prescription drug prices for patients and protect small pharmacy owners by regulating pharmacy benefit managers (PBMs). The passage of her bill, HB 961, would be a monumental achievement in the crusade for PBM transparency.

READ MORE

image

CSRO President Testifies Before Florida Senate Committee

posted: November 20, 2019 to CSRO News, State

CSRO President, Madelaine Feldman, MD, FACR, Testifies Before the Florida Senate Health Policy Committee, Explaining PBM Practices and How They are Hurting Florida’s Patients

READ MORE

image

Recapping the ACR Annual Meeting

posted: November 20, 2019 to CSRO News

Earlier this month, CSRO’s officers and board of directors traveled to Atlanta, Georgia to attend the American College of Rheumatology’s annual meeting.

READ MORE

image

Ohio PBM Reform Sees Immediate Results

posted: October 17, 2019 to State

For the last couple of years, the issue of Pharmacy Benefit Managers (PBMs) and their impact on the health care system has been a topic of much concern in both the state of Ohio and the nation as a whole.

READ MORE

image

Highlights from CSRO’s 2019 State Society Advocacy Conference (SSAC)

posted: September 20, 2019 to CSRO News

CSRO’s 2019 SSAC conference brought rheumatology advocates together from across the country to inspire action on issues affecting the practice of rheumatology.

READ MORE

CSRO Policy Update, August 2019, Issue 9

posted: August 30, 2019 to CSRO News, Policy Update

As CSRO prepares for the 2019 State Society Advocacy Conference (SSAC), healthcare has moved to the fore of national political conversations, providing the rheumatology profession much to discuss. Since its inception, CSRO’s guiding mission has been to ensure excellence in the field of rheumatology for rheumatologists and the patients that we take care of.

READ MORE

image

Federal Rebate Rule Withdrawn by White House

posted: July 12, 2019 to Federal

On July 11th, the White House announced that it was withdrawing its proposal to reformulate the way drug rebates work in federal programs.

READ MORE

image

CMS Issues Final Rule Affecting Patient Access and Prescription Drug Affordability

posted: June 14, 2019 to Federal

The Centers for Medicare and Medicaid (CMS) published its “Medicare Advantage and Part D Drug Pricing Final Rule” in May which seeks to increase drug pricing transparency, lower prescription drug costs, and improve patient medication adherence.

READ MORE

image

CSRO President Testifies Before Congress

posted: May 30, 2019 to CSRO News, Federal

Last week, the House Energy and Commerce Subcommittee on Health held a hearing entitled: “Improving Drug Pricing Transparency and Lowering Prices for American Consumers.” CSRO President, Dr. Madelaine Feldman, was invited to represent the Alliance for Specialty Medicine and deliver testimony at the hearing.

READ MORE

image

FDA Releases Final Guidance on Interchangeable Biosimilars

posted: May 24, 2019 to Federal

Last week, the FDA released its long anticipated final guidance for industry on “Considerations in Demonstrating Interchangeability with a Reference Product.”

READ MORE

image

CSRO offers Federal Policy Virtual “Town Hall” to Rheumatology Community

posted: April 9, 2019 to CSRO News, Federal

The gridlock immobilizing Congress has slowed the progress of health care legislation significantly, but it has not stopped key Federal agencies from proposing and implementing policies that have a far reaching impact on the practice of rheumatology.

READ MORE

image

CSRO Comments on Proposed Rule to Eliminate Safe Harbor Protections for Prescription Drug Rebates

posted: April 8, 2019 to CSRO News, Federal

The Coalition of State Rheumatology Organizations (CSRO) recently submitted comments on the Department of Health and Human Services (HHS) proposed rule amending the Federal anti-kickback statute.

READ MORE

image

Wisconsin Step Therapy Reform a Coalition Effort

posted: March 11, 2019 to State

CSRO, in partnership with the Wisconsin Step Therapy Coalition is taking the lead on step therapy reform in the state.

READ MORE

CSRO’s Dr. Robert Levin Discusses Drug Pricing in the U.S.

posted: February 28, 2019 to CSRO News, Federal

CSRO Board Member, Robert Levin, participated in the Healthcare Policy podcast on February 18 to discuss federal prescription drug pricing reform. In his capacity as a practicing physician, and president the Alliance for Transparent and Affordable Prescriptions, Dr. Levin provided expert testimony on drug pricing reform proposals and how the drug supply chain works.

READ MORE

image

The CSRO Holds Fellows Conference with Record Attendance

posted: February 14, 2019 to CSRO News

On February 9, 2019, the CSRO held its annual Fellows Conference in San Francisco, complete with a number of presentations on topics that surround today’s Rheumatologist.

READ MORE

image

Indiana Demands Policy Against Forced Medication Switches

posted: February 13, 2019 to State

Non-medical switching is a strategy used by health plans to reduce expenses by switching the prescription for a stable patient to a “preferred” drug — for reasons unrelated to the patients’ well-being and in some cases without warning.

READ MORE

Illinois Non-Medical Switching Law in Effect

posted: January 29, 2019 to State

A new law in Illinois ensures that commercial health plans deliver on policies they market and sell to Illinoisans. Prior to January 1st of this year, insurers in Illinois could change prescription drug coverage on a patient at any point during the year, and while patients were still locked into their plan. This practice is referred to as “non-medical switching” and can have serious negative health effects for patients.

READ MORE

image

PBMs and New Approaches to Drug Pricing in 2019

posted: January 10, 2019 to Federal

Without a doubt, lowering list-prices for prescription drugs was a national focus in 2018. Coupled with numerous advocacy organizations bringing increased awareness to Pharmacy Benefit Managers’ (PBMs) unfair practices, and their effect on drug prices, several reforms have sparked across the U.S. and are expected to increase in intensity in 2019.

READ MORE

CSRO Policy Update, January 2019, Issue 8

posted: January 3, 2019 to CSRO News, Policy Update

As the new year begins, I would like to reflect on the tremendous organizational successes that CSRO achieved in 2018. Over the past couple of years, CSRO made a commitment to deepening its ties with the societies it represents, and its allied patient and provider organizations. This year CSRO traveled to 20 state society meetings to bring increased awareness to the issues impacting practicing rheumatologists and patients in the U.S.

READ MORE

CSRO Submits IPI Comments

posted: January 3, 2019 to CSRO News, Federal

Prior to commenting on the proposed International Pricing Index Model (IPI) for Part B drugs, CSRO leadership met with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma to convey rheumatology's perspective.

READ MORE

image

CSRO Talks Accumulator Adjustment Programs at CBI Summit

posted: December 21, 2018 to CSRO News

Accumulator Adjustment Programs have become an increasingly prevalent issue since CSRO was first made aware of them in late 2017. Since then, the programs have been progressively crossing over from the employer to commercial space.

READ MORE

Hospitals Beginning To Practice Non-Medical Switching

posted: November 29, 2018 to State

CSRO has been fielding reports from physicians around the states who have found that their patients are no longer able to access their prescribed treatment. Some hospital systems are no longer carrying biologic originator products, meaning that patients must find an alternative site of care.

READ MORE

Express Scripts Announces New Formulary Design Option

posted: November 14, 2018 to Federal

This week, Express Scripts announced that it would provide clients with the ability to opt for its new National Preferred Flex Formulary Design. As opposed to favoring drugs that garner the most rebate dollars, the new benefit design intends to favor drugs that have lower list prices to begin with.

READ MORE

image

CSRO Hosts State Society Leaders at the ACR

posted: November 1, 2018 to CSRO News, State

On Monday, October 22nd, CSRO hosted a breakfast for state rheumatology society leaders present at the ACR. Attendees had the opportunity to learn more about emergent patient access issues, CSRO’s plans for 2019, and hear from a speaker who discussed implementation and compliance issues with existing patient access laws.

READ MORE

image

CSRO Discusses New Drug Payment Model with Key Agency Officials

posted: October 30, 2018 to CSRO News, Federal

Last week, CSRO’s Past President and National Advocacy Chair, Michael Schweitz, MD, participated in one-on-one discussions with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma and Special Advisor to the Administrator Jeet Guram, MD, to discuss details about the Trump Administration’s potential International Pricing Index Model for Medicare Part B Drugs.

READ MORE

image

New Data Emerges on Co-Pay Accumulator Programs

posted: September 27, 2018 to CSRO News

The CSRO has been deeply concerned about the expanded implementation of a new utilization management tool known as co-pay accumulator programs over the course of 2018.

READ MORE

image

Annual State Society Advocacy Conference a Success

posted: September 25, 2018 to CSRO News

The CSRO was excited to host many members of the state rheumatology societies and other partners in Chicago on Saturday, September 15th for the annual State Society Advocacy Conference (SSAC).

READ MORE

CSRO Policy Update, August 2018, Issue 7

posted: August 28, 2018 to CSRO News, Policy Update

As the last of the 2018 regular sessions wind down across the states, CSRO is happy to report that the year to date has been marked by a number of successes on the patient access front.

READ MORE

image

Illinois Enacts Non-medical Switching Protections

posted: August 28, 2018 to State

On Friday, August 24th, Illinois’ Governor signed HB4146 into law, providing patients much needed protections from non-medical switching.

READ MORE

CSRO Discusses Part B and D with CMS

posted: August 8, 2018 to CSRO News, Federal

Members of CSRO’s executive board recently met with CMS to discuss Part B and D drug pricing. Doctors Michael Schweitz, Madelaine Feldman, Greg Schimizzi traveled to D.C. to present CSRO’s feedback on recent proposals and provide rheumatology’s perspective on the programs.

READ MORE

image

CSRO attends National Conference of State Legislatures

posted: August 6, 2018 to CSRO News, State

Each year state legislators from across the country congregate to discuss innovative solutions that can be implemented to solve problems faced in common by various state legislatures.

READ MORE

image

2018 Session Capped with Approval of Three States’ Biosimilar Measures

posted: July 19, 2018 to State

Over the course of the past year, interchangeable biosimilar substitution laws with physician communication provisions have continued to find enormous success in the states.

READ MORE

CSRO Responds to RFI Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

posted: July 16, 2018 to CSRO News, Federal

CSRO has submitted their comments regarding the Request for Information (RFI) by the Department of Health and Human Services.

READ MORE

image

CSRO Attends FSR Conference

posted: July 16, 2018 to CSRO News, State

CSRO staff was pleased to attend the 2018 Florida Society of Rheumatology Conference in Orlando, Florida.

READ MORE

image

Maine Legislature Moves to Protect Patients

posted: June 29, 2018 to State

Late in Maine’s 2018 session, the legislature passed two separate patient protections measures of benefit to patients battling chronic illnesses.

READ MORE

image

Minnesota Enacts Step-therapy Reform Measure

posted: May 21, 2018 to State

On Friday, May 15th, Governor Mark Dayton of Minnesota signed HF3196 into law providing important patient protections to Minnesota patients.

READ MORE

image

Non-Medical Switching Protections Advance in Illinois

posted: May 14, 2018 to State

HB4146, a bill that protects patients from mid-year formulary changes, has been making steady progress in the Illinois legislature this year. After passing the House, it was assigned to the Special Committee of Medicaid Managed Care, where it was heard in a subject matter hearing on Wednesday, May 9th.

READ MORE

image

Alaska Legislature Approves Biosimilar Substitution Measure

posted: May 1, 2018 to State

Pending the Governor’s signature, passage of the law would cap a multi-year effort to improve future uptake of interchangeable biosimilars that faced numerous obstacles.

READ MORE

image

CSRO Travels to the Wisconsin Rheumatology Association’s Annual Meeting

posted: March 23, 2018 to State

​Last weekend CSRO Vice President, Dr. Madelaine Feldman, traveled to the Wisconsin Rheumatology Association’s annual meeting to represent CSRO, and educate attendees on the role that Pharmacy Benefit Managers (PBMs) play in inflating the price of prescription drugs.

READ MORE

image

Michigan Enacts Biosimilar Substitution Measure

posted: March 9, 2018 to State

In late February, Michigan enacted a biosimilar substitution law that promises to improve uptake of biosimilars, while maintaining appropriate patient protections by requiring notification of substitutions to prescribers.

READ MORE

image

New Mexico Legislature Send Step-Therapy Reform to Governor’s Desk

posted: February 14, 2018 to State

The New Mexico state legislature overwhelmingly approved SB 11, a bill that promises to reform the use of step-therapy protocols by insurers.

READ MORE

image

CSRO Nominee Selected for CMS Technical Expert Panel

posted: February 8, 2018 to CSRO News

The CSRO is pleased to announce that its nominee, Kent “Kwas” Huston, MD, from the Kansas City Physicians Partners, has been selected to serve on the Centers for Medicare & Medicaid Services (CMS) Technical Expert Panel (TEP).

READ MORE

CSRO Policy Update, January 2018, Issue 6

posted: January 30, 2018 to CSRO News, Policy Update

The CSRO closed out 2017 with legislative and regulatory victories across the country that positively affected the lives of our patients and practices.

READ MORE

image

CSRO & Allies Talk Utilization Management in Albany

posted: January 18, 2018 to State

On Tuesday, January 16th CSRO staff joined allies in Albany, New York to educate lawmakers on utilization management, and pending legislation that promises to improve patient access and continuity of care.

READ MORE

image

CSRO Presents on PBMs at the Board of Hispanic Caucus Chairs Conference

posted: December 14, 2017 to CSRO News, Federal

CSRO Vice President, Dr. Madelaine Feldman recently presented on Pharmacy Benefit Managers and utilization management tools at the Board of Hispanic Caucus Chairs meeting in Las Vegas, Nevada.

READ MORE

image

FSR President Testifies on PBMs and the Rebate System

posted: December 14, 2017 to State

Dr. Robert Levin, President of the Florida Society of Rheumatology recently testified to the House Health Innovation Subcommittee on the role that Pharmacy Benefit Managers have played in inflating the cost of prescription drugs.

READ MORE

image

CSRO & FSR Discuss Utilization Management in Tallahassee

posted: December 11, 2017 to CSRO News, State

On Tuesday, December 5th, CSRO hosted a reception for Florida legislators in partnership with the Florida Society of Rheumatology (FSR). An array of stakeholders including patients and physicians met and spoke with legislators that are deeply invested in CSRO and FSR’s shared priorities.

READ MORE

FDA Biosimilars Educational Material

posted: December 7, 2017 to Federal

To date, the U.S. Food and Drug Administration (FDA) has approved seven biosimilars, and some are already on the market. As the biosimilars market continues to grow, there are still a lot of questions from both patients and physicians about these important new treatment options.

READ MORE

image

CSRO Opposes Efforts to Establish a National Benchmark Plan Standard for Prescription Drugs

posted: November 29, 2017 to CSRO News, Federal

The CSRO has submitted comments to CMS expressing concerns with their intent to establish a national benchmark plan standard for prescription drugs in future years.

READ MORE

image

CSRO Responds to Federal Innovation Center RFI

posted: November 20, 2017 to Federal

The CSRO has responded to a request for information (RFI) from the Innovation Center as the federal agency plans for a new direction. The comments submitted focus on specific issues that uniquely impact practicing rheumatologists and the patients they serve.

READ MORE

image

CSRO Presents at the Patient and Health Advocacy Bio Summit

posted: October 5, 2017 to CSRO News, Federal

Dr. Madelaine Feldman traveled to Washington D.C. recently to attend the Patient and Health Advocacy Bio Summit.

READ MORE

image

CSRO and Allies Submit Comments to Anthem on Utilization Management Changes for Osteoarthritis Patients

posted: September 27, 2017 to CSRO News

As patient and physician advocates, the Coalition of State Rheumatology Organizations (CSRO) actively monitors changes that affect physician’s ability to effectively treat their patients and operate their practices.

READ MORE

image

CSRO Delivers Testimony on Utah Step Therapy

posted: September 22, 2017 to CSRO News, State

On September 20, 2017, Dr. Joshua Stolow traveled to Utah to testify on the necessity of patient protection legislation addressing step therapy protocols.

READ MORE

image

CSRO Submits Comments to CMS on Proposed Revisions for 2018

posted: September 13, 2017 to CSRO News, Federal

As patient and physician advocates, the CSRO actively monitors regulatory changes that affect physician’s ability to effectively treat their patients and operate their practices. As such, the CSRO took note of and discussed revisions proposed by the Center for Medicare and Medicaid Services for 2018.

READ MORE

image

Legal Challenges to Nevada Drug Transparency Law Forecast Future Hurdles for Lawmakers

posted: September 6, 2017 to State

Nevada Governor Brian Sandoval signed a landmark drug transparency law in June that focuses on diabetes drug manufacturers and their intermediaries more broadly.

READ MORE

image

Escalating Cost of Prescription Drugs Facilitated by Lack of Transparency

posted: August 30, 2017 to Federal

The expansive list of actors involved in delivering prescription drugs to patients substantially inhibits patients from making fully informed treatment and purchasing decisions.

READ MORE

image

Step-Therapy Legislation Nears Effective Enrollment Date in Texas

posted: August 21, 2017 to State

Patients and physicians in Texas won a major victory against the step-therapy protocols instituted by insurance companies this spring with the passage of Senate Bill 680.

READ MORE

image

CSRO Submits Comments in Response to 2018 QPP Proposed Rule

posted: August 21, 2017 to CSRO News, Federal

The Coalition of State Rheumatology Organizations (CSRO) and several state societies submitted comments to CMS today in response to the CY 2018 Updates to the Quality Payment Program.

READ MORE

image

Lawsuits Target Pharmacies Over Prescription Drug Costs

posted: August 11, 2017 to CSRO News, Federal

As patients, providers, and politicians alike look for answers to the soaring cost of prescription drugs, some patients have taken matters into their own hands. A series of lawsuits have popped up across the country targeting pharmacies and their relationship to pharmacy benefit managers.

READ MORE

image

FDA Creates Pathway for Interchangeable Biologics

posted: June 29, 2017 to Federal, State

The FDA has released its highly anticipated but long delayed interchangeability guidelines, and the market seems primed for new developments.

READ MORE

image

AMA House of Delegates Policy Update

posted: June 28, 2017 to Federal

At the AMA’s Annual House of Delegate Meeting, hundreds of medical professionals gathered to discuss and address a wide range of healthcare issues, including the opioid crisis, physician burnout, regulating physician assistants and advanced practice registered nurses, and of course, healthcare reform and drug pricing.

READ MORE

image

States move to enforce FDA’s Biosimilar Interchangeability Guidelines from the Ground Up

posted: June 27, 2017 to Federal, State

The Food and Drug Administration’s guidelines for biosimilar interchangeability, released in January 2017, have come under renewed focus with concerns about patients being switched onto biosimilars by insurers without consultation with their physicians.

READ MORE

image

California Takes Aim at Pharmacy Benefit Managers With Assembly Bill 315

posted: June 23, 2017 to State

California’s Assembly Bill 315, which takes aim at Pharmacy Benefit Managers (PBMs), recently cleared the Assembly floor, and is now headed to the Senate for consideration.

READ MORE

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

posted: June 20, 2017 to State

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

READ MORE

image

Senate HELP Committee Wades into Drug Prices Debate

posted: June 16, 2017 to Federal

Despite intractable differences between the parties on healthcare policy, the Senate’s Health, Education, Labor, and Pensions Committee (HELP) convened a hearing this week to frame future efforts in combating high drug prices.

READ MORE

image

The Atlantic Hosts Biosimilars Policy Roundtable.

posted: June 15, 2017 to State

The Atlantic recently concluded its policy roundtable on biosimilars June 7th, with the third and final installment titled: “The Next Drugs: An Atlantic Policy Update on Biosimilars.”

READ MORE

Leading Health Organizations Announce Launch of Alliance for Transparent & Affordable Prescriptions

posted: June 13, 2017 to Federal

Health leaders today announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.

READ MORE

image

Maryland Enacts Biosimilars Bill

posted: May 31, 2017 to State

Maryland became the 35th state to approve of regulations and access for biosimilar medicines.

READ MORE

image

Minnesota Enacts HF712

posted: May 25, 2017 to State

Minnesota's Governor signed HF712 into law, a bill for biosimilars.

READ MORE

CSRO Policy Update, April 2017, Issue 5

posted: May 24, 2017 to CSRO News, Policy Update

In this issue: President’s Message; States Stride Toward Addressing; Patient Access Legislation; State Maps on Step Therapy & Biosimilars; Fellows Assemble in San Francisco to Prepare for Next Step; The Alliance for Transparent & Affordable Prescriptions; The Rebate System; ARA: CSRO Vice President Presents on PBMs and the Rebate System; CSRO discusses Biosimilars, Drug Pricing, and PBMs with CRA; CSRO Promotes Advocacy at 2017 CCR Conference; CSRO Participates in 2nd Annual National Policy & Advocacy Summit; Save the Date

READ MORE

image

Step Therapy Legislative Update: Texas Governor Signs Step Therapy Bill into Law

posted: May 24, 2017 to State

The CSRO is pleased to announce that Texas Governor Greg Abbott has officially signed step therapy bill SB 680 into law.

READ MORE

image

ARA: CSRO Vice President Presents on PBMs and the Rebate System

posted: May 15, 2017 to CSRO News, State

The CSRO is pleased to report that CSRO Vice President Madeleine Feldman, MD, FACR, presented at the Arkansas Rheumatology Association, giving attendees an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs).

READ MORE

image

Biosimilars Bill headed to Nebraska Governor

posted: May 10, 2017 to State

Legislation that provides the substitution and regulation of biosimilars, LB481, was approved by Nebraska’s Unicameral Legislature on a vote of 47 – 0. The bill now goes to Governor Pete Ricketts for his expected signature.

READ MORE

image

Step Therapy Legislative Update: Texas Bill is Headed to Governor’s Desk

posted: May 10, 2017 to State

The CSRO is happy to announce that SB 680, step therapy bill introduced in the Texas Senate on January 31, has passed both the Senate and the House and is now headed to Governor Greg Abbott’s desk.

READ MORE

image

Step Therapy Legislative Update: Iowa Governor Signs Step Therapy Bill into Law

posted: May 10, 2017 to State

The CSRO is very happy to announce that Iowa Governor Terry Branstad has officially signed HF 233, step therapy bill introduced in the Iowa House by Representative Joel Fry (R, 27th) on January 23, into law.

READ MORE

image

Biosimilars Bills Moved in South Carolina and Nebraska

posted: May 1, 2017 to State

HB3438 was signed by South Carolina Governor Henry McMaster. In Nebraska, LB481, a bill for biosimilars access and regulation, was approved on first round debate.

READ MORE

image

State Advocacy Spotlight: Step Therapy Legislation Continues to Progress in Florida

posted: April 24, 2017 to State

Like other states across the country, efforts to address step therapy in Florida are underway and making great progress as key legislation continues to move forward.

READ MORE

image

Biosimilars Bill Signed in Kansas

posted: April 19, 2017 to State

On April 13, HB 2055 was signed by Governor Sam Brownback. It included critical patient safety rules that involved a communication within 5 business days from pharmacists to physicians about any biosimilar substitutions.

READ MORE

image

Step Therapy Legislative Update: Iowa Bill Makes Its Way to Governor’s Desk

posted: April 18, 2017 to State

The CSRO is pleased to announce that HF 233, step therapy bill introduced in the Iowa House by Representative Joel Fry (R, 27th) on January 23, has passed both the House and the Senate and is now headed to Governor Terry Branstad’s desk.

READ MORE

CRA: How Will Biosimilars Change Rheumatology, Rising Drug Prices: Exposing the Hidden Rebate System

posted: April 14, 2017 to State

The CSRO was delighted to join the California Rheumatology Alliance in an informal presentation on the effect of biosimilars on rheumatology, and an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs). The panel that presented included Dr. Greg Schmizzi on biosimilars, with Dr. Madelaine Feldman, Pharmacist Keith Bradbury, and Attorney David Balto on PBMs.

READ MORE

image

Biosimilars Bill Awaits Governor’s Signature in South Carolina

posted: April 13, 2017 to State

HB3438 has unanimously passed both legislative chambers in South Carolina, and awaits Governor Henry McMaster’s signature.

READ MORE

image

Biosimilars Bill Signed in New Mexico

posted: April 7, 2017 to State

Governor Susana Martinez signed HB260, which provides important pathways for patient access to biologic medications, while also creating much needed safety rules that include a mandate that pharmacists must communicate to physicians about a biosimilar substitution within 5 days of its dispensing.

READ MORE

image

Kansas’ Bill for Biosimilars Awaits the Governor’s Signature

posted: April 4, 2017 to State

In Kansas, HB2055 has reached approval in the House and Senate and awaits the Governor’s signature. This bill provides important pathways for access to biologic medications.

READ MORE

image

Formulary Changes Hurt the Patients Most

posted: March 29, 2017 to CSRO News, Federal

Rheumatologists are at the forefront of innovative treatments for patients with complex autoimmune diseases such as rheumatoid arthritis.

READ MORE

image

New Legislation Could Shine a Light on the Elusive World of Prescription Drug Pricing

posted: March 27, 2017 to Federal

Ever-increasing drug prices have recently been at the forefront of the healthcare debate in America, and a new bill introduced in Congress last week may be the important first step in shedding light on the intermediaries who play a huge yet largely unnoticed role in drug pricing: Pharmacy Benefit Managers (PBMs).

READ MORE

image

Biosimilars Legislative Status Update — March 2017

posted: March 21, 2017 to State

Montana and Iowa recently joined the now 28 states to provide pathways for access to Biosimilars, and create much needed patient safety rules, including guidelines for dispensing pharmacists to communicate to physicians about biosimilar substitutions.

READ MORE

image

CSRO Submits Interchangeability Comments to FDA

posted: March 21, 2017 to CSRO News, Federal

As patient and physician advocates, we have been deeply involved in the debate surrounding implementation of the Biologics Price Competition and Innovation Act (BPCIA).

READ MORE

image

Step Therapy Legislative Update: Iowa Fail First Advocacy Day

posted: March 17, 2017 to State

Like multiple other states across the country, Iowa is tackling step therapy reform this year and is making great progress as efforts continue to move forward.

READ MORE

State Advocacy Spotlight: Step Therapy in New Mexico and Texas

posted: March 15, 2017 to State

It was another active week for step therapy legislation across the country; here are some highlights from New Mexico and Texas.

READ MORE

image

Iowa Enacts Legislation for Biosimilars

posted: March 14, 2017 to State

Iowa joined the 27 other states, including Puerto Rico, that have passed legislation to provide pathways for access to Biosimilars, and create much needed patient safety rules, including a guideline for pharmacists to communicate to physicians about a Biosimilar substitution within 5 business days of its dispensing.

READ MORE

In the News: When Critical Medications Leave the Formulary, Patients Can Be Devastated

posted: March 7, 2017 to CSRO News, State

At the beginning of this new year, a worrisome change took effect for patients with chronic illnesses across Minnesota. Many patients have just become aware that their current medical treatment will no longer be covered, which may have a serious impact on their health in 2017 and lead to consequences beyond.

READ MORE

image

The CSRO Holds Another Successful Fellows Conference

posted: March 1, 2017 to CSRO News

On February 18, the CSRO held another successful Fellows Conference, complete with a host of interesting presentations on pertinent topics.

READ MORE

image

Montana Passes Legislation for Biosimilars

posted: February 24, 2017 to State

The State of Montana joined the 26 other states, including Puerto Rico, that have now passed legislation to provide pathways for access to Biosimilars, and create much needed patient safety rules...

READ MORE

image

State Advocacy Spotlight: Biosimilars in Nebraska

posted: February 15, 2017 to State

Attempting to join the 26 other states that have enacted laws for Biosimilars and their dispensing, Nebraska’s Unicameral Legislature will hear LB481 in the Health and Human Services Committee.

READ MORE

image

State Advocacy Spotlight: Step Therapy in Oregon

posted: February 13, 2017 to State

Like multiple other states across the country, Oregon is tackling step therapy reform this year and has made great progress so far.

READ MORE

CSRO Policy Update, January 2017, Issue 4

posted: February 13, 2017 to CSRO News, Policy Update

In this issue: President’s Message; Biosimilar Advocacy Update; New CSRO Advocacy Initiative; Step Therapy Advocacy Update; Non-Medical Switching Legislation; Save the Date

READ MORE

image

CSRO Supports Biosimilars Legislation in Multiple States this Week

posted: February 10, 2017 to State

Legislation is being unveiled across the country to address Biosimilars, and create the pathways needed for pharmacists to dispense Biosimilar substitutions to patients, while communicating the substitution with the patient’s physician in a timely manner.

READ MORE

Step Therapy Legislative Update

posted: February 10, 2017 to State

It was another active week for step therapy legislation across the country; here are some highlights from Ohio and Iowa.

READ MORE

image

CSRO Supports Step Therapy Legislation in Utah, Texas, and Iowa

posted: February 3, 2017 to CSRO News, State

This week was a big one for step therapy legislation, which moved forward in three key states.

READ MORE

image

Step Therapy Legislation Introduced in Iowa is Moving Forward to Full House Committee for Review

posted: February 1, 2017 to State

A step therapy bill in Iowa received unanimous support from a House subcommittee will now be heard by the full House committee in the coming weeks.

READ MORE